Psychoneuroendocrine aspects of temporolimbic epilepsy: Part I. Brain, reproductive steroids, and emotions

Psychosomatics

Volumn 40, Issue 2, 1999, Pages 95-101

  Herzog, Andrew G ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID RECEPTOR; ANDROSTANEDIOL; ANDROSTANOLONE; ESTRADIOL; ESTROGEN; N METHYL DEXTRO ASPARTIC ACID; PROGESTERONE; STEROID HORMONE; TESTOSTERONE;

AFFECTIVE NEUROSIS; AMYGDALOID NUCLEUS; ANXIETY NEUROSIS; ARTICLE; EMOTION; ENVIRONMENTAL FACTOR; EPILEPTOGENESIS; GABAERGIC TRANSMISSION; HEREDITY; HORMONE ACTION; HORMONE RELEASE; HORMONE SUBSTITUTION; KINDLING; MALE; NONHUMAN; RAT; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; TEMPORAL LOBE EPILEPSY;

EID: 0033026796     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(99)71254-5     Document Type: Article

References (82)

1. Gloor P: Experiential phenomena of temporal lobe epilepsy: facts and hypothesis. Brain 1990; 113:1673-1694
2. Herzog AG: A hypothesis to integrate partial seizures of temporal lobe origin and reproductive endocrine disorders. Epilepsy Res 1989; 3:151-159
3. Hardy RW: Unit activity in Premarin-induced cortical epileptogenic foci. Epilepsia 1970; 11:179-186
4. Logothetis J, Harner R, Morrell F, et al: The role of estrogens in catamenial exacerbation of epilepsy. Neurology 1959; 9:352-359
5. Grant ECG, Pryse-Davies J: Effect of oral contraceptives on depressive mood changes and on monoamine oxidase and phosphatases. Br Med J 1968; iii:777-780
6. Klaiber EL, Broverman DM, Vogel W, et al: Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 1979; 36:550-554
7. Sevringhaus EL: The relief of menopause symptoms by estrogenic preparations. JAMA 1935; 104:624-628
8. Sherwin BB: Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 1988; 14:177-187
9. Sherwin BB: The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991; 72:336-343
10. Nathorst-Boos J, von Schoultz B, Carlstrom K: Elective ovarian removal and estrogen replacement therapy - effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 1993; 14:283-293
11. Young JK: A possible neuroendocrine basis of two clinical syndromes: anorexia nervosa and the Klein-Levin syndrome. Physiol Psychol 1975; 3:322-330
12. Nicoletti F, Speciale C, Sortino MA, et al: Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia 1985; 26:252-257
13. Backstrom T, Zetterlund B, Blom S, et al: Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol Scand 1984; 69:240-248
14. Herzog AG: Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 1986; 36:1607-1610
15. Landgren S, Backstrom T, Kalistratov G: The effect of progesterone on the spontaneous interictal spike evoked by the application of penicillin to the cat's cerebral cortex. J Neurol Sci 1978; 36:119-133
16. Selye H: The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (Metrazol). J Lab Clin Med 1941; 27:1051-1053
17. Frye CA: The neurosteroid 3 alpha, 5 alpha-THP has antiseizure properties and possible neuroprotective effects in an animal model of epilepsy. Brain Res 1995; 696:113-120
18. Freeman EW, Purdy RH, Coutifaris C, et al: Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinol 1993; 58:478-484
19. Paul SM, Purdy RH: Neuroactive steroids. FASEB J 1992; 6:2311-2139
20. Majewska MD, Harrison NL, Schwartz RD, et al: Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986; 232:1004-1007
21. Costa A-MN, Spence KT, Smith SS, et al: Withdrawal from the endogenous steroid progesterone results in GABA-A currents insensitive to benzodiazepine modulation in rat CA1 hippocampus. J Neurophysiol 1995; 74:464-469
22. Gallo MA, Smith SS: Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety. Pharmacol Biochem Behav 1993; 46:897-904
23. Smith SS: Estradiol administration increases neuronal responses to excitatory amino acids as a long-term effect. Brain Res 1989; 503:354-357
24. Smith SS, Waterhouse BD, Woodward DJ: Locally applied estrogens potentiate glutamate-evoked excitation of cerebellar Purkinje cells. Br Res 1988; 475:272-282
25. Pouliot WA, Handa RJ, Beck SG: Androgen modulates N-methyl-D-aspartate-mediated depolarization in CA1 hippocampal pyramidal cells. Synapse 1996; 23:10-19
26. Rubinow DR, Schmidt PJ: Androgens, brain, and behavior. Am J Psychiatry 1996; 153:974-984
27. Davidson JM, Camargo CA, Smith ER: Effects of androgen on sexual behavior in hypogonadal men. J Clin Endocrinol Metab 1979; 48:955-958
28. McEwen BS: Steroid hormones: effect on brain development and function. Horm Res 1992; 37(suppl):S1-S10
29. Nishizuka M, Arai Y: Sexual dimorphism in synaptic organization in the amygdala and its dependence on neonatal hormonal environment. Brain Res 1981; 212:31-38
30. Woolley CS, McEwen BS: Rules of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 1993; 336:293-306
31. Woolley CS, Jurgen Wenzel H, Schwartzkroin PA: Estradiol increases the frequency of multiple synapse boutons in the hippocampal CA1 region of the adult female rat. J Compar Neurol 1996; 373:108-117
32. Gordon GS: Hormones and metabolism, influence of steroids on cerebral metabolism in man. Recent Prog Horm Res 1956; 12:153-156
33. Namba H, Sokoloff L: Acute administration of high doses of estrogen increase utilization throughout brain. Brain Res 1984; 291:391-394
34. Penotti M, Farina M, Castiglioni E, et al: Alteration in the pulsatility index values of the internal carotid and middle cerbral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study. Am J Obstet Gynecol 1996; 175:606-611
35. Okhura T, Isse K, Akazawa K, et al: Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J 1994; 41:361-371
36. Clark JH, Peck EJ, Anderson JN: Oestrogen receptors and antagonism of steroid hormone action. Nature 1974; 251:446-448
37. Miranda RC, Sohrabji F, Toran-Allerand CD: Interactions of estrogen with the neurotrophins and their receptors during neural development. Horm Behav 1994; 28:367-375
38. Briggs M, Briggs M: The relationship between monoamine oxidase activity and sex hormone concentrations in human blood plasma. J Reprod Fertil 1972; 29:447-450
39. Fishman J: Biological action of catechol estrogens. Endocrinology 1981; 89:59-65
40. Pfaff DW, Keiner M: Estradiol-concentrating cells in the rat amygdala as part of a limbic-hypothalamic hormone-sensitive system, in The Neurobiology of the Amygdala, edited by Eleftheriou BE. New York, Plenum, 1973, pp. 775-792
41. Stumpf WE: Steroid concentrating neurons in the amygdala, The Neurobiology of the Amygdala, edited by Eleftheriou BE. New York, Plenum, 1973, pp. 763-774
42. Fink G, Sumner BE, Rosie R, et al: Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 1996; 16:325-344
43. Halbreich U: Role of estrogen in postmenopausal depression. Neurology 1997; 48 (suppl. 7):S16-S20
44. Sherwin BB, Suranyi-Cadotte BE: Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women. Biol Psychiatry 1990; 28:339-348
45. Schneider LS, Small GW, Hamilton SH, et al: Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry 1997; 5:97-106
46. Gee KW: Steroid modulation of the GABA/benzodiazepine receptor-linked chloride ionophore. Mol Neurobiol 1988; 2:291-317
47. Phillis JW: Potentiation of the depression by adenosine of rat cerebral cortical neurones by progestational agents. Br J Pharmacol 1986; 89:693-702
48. Hsueh AJW, Peck EJ, Clark JH: Control of uterine estrogen receptor levels by progesterone. Endocrinology 1976; 98:438-444
49. Bitran D, Hilvers RJ, Frye CA: Chronic anabolic-androgenic steroid treatment affects brain GABA(A) receptor-gated chloride ion transport. Life Sci 1996; 58:573-583
50. Sholl SA, Kim KL: Androgen receptors are differentially distributed between right and left cerebral hemispheres of the fetal male rhesus monkey. Brain Res 1990; 516:122-126
51. Hutchison JB, Steimer TJ, Hutchison RE: Formation of behaviorally active estrogen in the dove brain: induction of preoptic aromatase by intracranial testosterone. Neuroendocrinol 1986; 43:416-427
52. Papez JW: A proposed mechanism of emotion. Arch Neurol Psychiatry 1937; 38:725-743
53. Mesulam MM: Large scale neurocognitive networks and distributed processing for attention, language and memory. Ann Neurol 1990; 28:597-613
54. Geschwind N: Disconnexion syndromes in animals and man (Part 1). Brain 1965; 88:237-294
55. Geschwind N: Disconnexion syndromes in animals and man (Part 2). Brain 1965; 88:585-644
56. Kluver H, Bucy P: "Psychic blindness" and other symptoms following bilateral temporal lobectomy in rhesus monkey. Am J Physiol 1937; 119:352-353
57. Kluver H, Bucy P: Preliminary analysis of functions of the temporal lobes in monkeys. Arch Neurol Psychiatry 1939; 42:979-1000
58. Downer JL: Changes in visual gnostic functions and emotional behavior following unilateral temporal pole damage in the "split brain" monkey. Nature 1961; 191:50-51
59. Bear DM: Temporal lobe epilepsy: a syndrome of sensory-limbic hyperconnection. Cortex 1979; 15:357-384
60. King GL, Dingledine R, Giacchino JL, et al: Abnormal neuronal excitability in hippocampal slices from kindled rats. J Neurophys 1985; 54:1295-1304
61. Van Hoesen GW: The differential distribution, diversity and sprouting of cortical projections to the amygdala in the Rhesus monkey, in The Amygdaloid Complex, edited by Ben-Ari Y. INSERM Symposium 20. New York, Elsevier, 1981, pp. 77-90
62. Bear DM, Fedio P: Quantitative analysis of interictal behavior in temporal lobe epilepsy. Arch Neurol 1977; 34:454-467
63. Sawyer CH: Functions of the amygdala related to the feedback actions of gonadal steroid hormones, in The Neurobiology of the Amygdala, edited by Eleftheriou BE. New York, Plenum, 1972, pp. 745-762
64. Lesch KP, Bengel D, Heils A, et al: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274:1527-1531
65. McInnes LA, Escamilla MA, Service SK, et al: A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proc Natl Acad Sci USA 1996; 93:13060-13065
66. Gainotti G: Emotional behavior and hemispheric side of the lesion. Cortex 1972; 8:41-55
67. Ross ED, Homan RW, Buck R: Differential hemispheric lateralization of primary and social emotions. Neuropsychiatry Neuropsychol Behav Neurol 1994; 7:1-19
68. Flor-Henry P: On certain aspects of the localization of the cerebral systems regulating and determining emotion. Biol Psychiatry 1979; 14:677-697
69. Finn DA, Roberts AJ, Lotrich F, et al: Genetic differences in behavioral sensitivity to a neuroactive steroid. J Pharmacol Exp Ther 1997; 280:820-828
70. Bromfield EB, Altshuler L, Leiderman DB, et al: Cerebral metabolism and depression in patients with complex partial seizures [published erratum appears in Arch Neurol 1992;49:976]. Arch Neurol 1992; 49:617-623
71. Altshuler LL, Devinsky O, Post RM, et al: Depression, anxiety, and temporal lobe epilepsy. Laterality of focus and symptoms. Arch Neurol 1990; 47:284-288
72. Himmelhoch JM: Mixed states, manic-depressive illness, and the nature of mood. Psychiatric Clin North Am 1979; 2:449-459
73. Hesdorffer DC, Hauser WA, Annegers JF, et al: Is depression an independent risk factor for epilepsy? Epilepsia 1994; 35(suppl 8):100
74. Falconer MA, Serafetinides EA, Corsellis JAN: Etiology and pathogenesis of temporal lobe epilepsy. Arch Neurol 1964; 10:233-248
75. Theodore WH: Neuroimaging and neuropathology in epilepsy and psychiatry, in Epilepsy and Behavior, edited by Devinsky O, Theodore WH. New York, Wiley-Liss, 1991, pp. 291-301
76. Schmidt PJ, Nieman LK, Danaceau MA, et al: Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998; 338:209-216
77. Herzog AG: Perimenopausal depression: possible role of anomalous brain substrates. Brain Dysfunction 1989; 2:146-154
78. Herzog AG: Role of anomalous brain substrates in the late luteal phase dysphoric disorder. Psychoneuroendocrinology (in press)
79. Blumer D, Herzog AG, Himmelhoch J, et al: To what extent do premenstrual and interictal dysphoric disorder overlap? Significance for therapy. J Affect Disord 1998; 48:215-225
80. Post RM: Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149:999-1010
81. Nakajima T, Daval JL, Gleiter CH, et al: c-Fos mRNA expression following electrical-induced seizure and acute nociceptive stress in mouse brain. Epilepsy Res 1989; 4:156-159
82. Teicher MH, Glod CA, Surrey J, et al: Early childhood abuse and limbic system ratings in adult psychiatric outpatients. J Neuropsychiatry Clin Neurosci 1993; 5:301-306